Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Availability of New Drugs and Americans' Ability to Work

This work examined the extent to which the introduction of new drugs has increased society's ability to produce goods and services by increasing the number of hours worked per member of the working-age population. Under very conservative assumptions, the estimates indicated that the value of the increase in ability to work attributable to new drugs is 2.5 times as great as expenditure on new drugs.

The study also found that the potential of medicines to increase employee productivity should be considered in the design of drug-reimbursement policies. Conversely, policies that broadly reduce the development and utilization of new drugs may ultimately reduce our ability to produce other goods and services.

Due to copyright issues, this study is only available through the JOEM website.

Commentary and Testimony Page

The Importance of Evidence, Value, Access and Innovation in 2016

Last year, in our 2015 Health Care Outlook published in Chain Drug Review, I highlighted the recent announcement by the U.S. Department of Health and...
Newsletter Volume

E.V.I.dently November 2015

MessageCan We Work Together to Ensure Patient Access to Treatments and Encourage Innovation?Has biopharmaceutical innovation brought value and made a...
Blog Post

Can We Work Together to Ensure Patient Access to Treatments and Encourage Innovation?

Is it possible for all health care stakeholders to work together to develop solutions for containing costs that ensure patient access to care and...
Blog Post

Pharmaceutical Innovation’s Role in the Panorama of Health System Improvement and Population Health

When he announced the launch of the White House Precision Medicine Initiative, President Obama said, “If we have the opportunity to prevent hurt and...
Press Release

Specialty Medications: Shifting the Focus From “How Much” We Spend to “How Well” We Spend

Washington, DC, June 9, 2014—As health care decision-makers grapple with how to ensure access to specialty medications, the University of Michigan...
Press Release

NPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer

WASHINGTON, DC (April 24, 2013) The National Pharmaceutical Council today welcomed the news that the Patient-Centered Outcomes Research Institute (...
Press Release

National Pharmaceutical Council Welcomes Amgen as Its Newest Member

Washington, D.C. (January 16, 2013)—The National Pharmaceutical Council (NPC) today welcomed biotechnology pioneer Amgen as its newest member. Joshua...
Press Release

Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity

(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...
Commentary and Testimony Page

The Importance of Evidence, Value, Access and Innovation in 2016

Last year, in our 2015 Health Care Outlook published in Chain Drug Review, I highlighted the recent announcement by the U.S. Department of Health and...
Commentary and Testimony Page

Linking Chronic Conditions to Medication Adherence and Productivity

It's no secret that chronic disease is the major driver of health care costs in the United States, accounting for two-thirds of the rise in health...
Commentary and Testimony Page

Comparative Effectiveness Research: What Will Employers Do With the Information?

For years now, employers have expressed concern about the cost of providing health care to their employees and its impact on the competitiveness of...
Commentary and Testimony Page

Moving from “Comparative” to “Effectiveness” in Health Care Treatments

The early discussions about comparative effectiveness research (CER) focused on defining “comparative” and determining the implications for...
YouTube Videos

CER and Its Impact on Pharma Innovation

Dr. Darius Lakdawalla, director of research at the Schaeffer Center for Health Policy and Economics at the University of Southern California,...
YouTube Videos

NPC/Benfield CER Employer Survey Results

Chuck Reynolds, president of the employer practice at the Benfield Group, discusses the findings from his NPC-sponsored research, "Comparative...
YouTube Videos

IBI's Tom Parry on Employers and Health Investments

Integrated Benefits Institute President Tom Parry, PhD, sat down with NPC to discuss how employers today are defining the value of their health...
YouTube Videos

Health & Productivity as a Business Strategy

National Pharmaceutical Council President Dan Leonard interviews Dr. Ron Loeppke, executive vice president of Alere Inc. and Co-Chairman of the...
Blog Post

Can We Work Together to Ensure Patient Access to Treatments and Encourage Innovation?

Is it possible for all health care stakeholders to work together to develop solutions for containing costs that ensure patient access to care and...
Blog Post

Pharmaceutical Innovation’s Role in the Panorama of Health System Improvement and Population Health

When he announced the launch of the White House Precision Medicine Initiative, President Obama said, “If we have the opportunity to prevent hurt and...
Blog Post

At the HHS Pharmaceutical Forum, We Need to Consider All Health Care Costs

On November 20, stakeholders will come together for a day-long event—“HHS Pharmaceutical Forum: Innovation, Access, Affordability and Better Health”—...
Blog Post

Value Is in the Eye of the Beholder? NPC Takes Closer Look at ICER Framework

In recent months, a number of health organizations have developed “value assessment frameworks,” which are designed to inform coverage and treatment...

Imputing Productivity Gains From Clinical Trials

Researchers developed a new method to capture the impact that medicines may have on reducing the...

Comparative Effectiveness Research: Do Employers Care? What Will They Do? What About Productivity?

A survey by NPC and the Benfield Group found that one of the benefits employers are looking for...

Comparative Effectiveness Research: Do Employers Care? What Will They Do?

A survey of employers found that they care about comparative effectiveness research and view it as...
  •  
  • 1 of 9
  • >